UNSPSC 51401568: Metaclazepam hydrochloride

This classification denotes a benzodiazepine with the molecular formula C18H18BrClN2O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P21PFK193T, chemically known as 2,3-dihydro-7-bromo-5-(2-chlorophenyl)-2-(methoxymethyl)-1-methyl-1h-1,4-benzodiazepine hcl but more generally known as metaclazepam hydrochloride, which bears US NIH Compound Identifier 162950. European Medicines Agency schedules Metaclazepam hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03181MIG.

UNSPSC 51401568 Metaclazepam hydrochloride is a Commodity code that shows minimal alignment with actual state and local procurement activity. The single recent opportunity in the dataset—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—solicits naloxone and safe drug deactivation systems, products unrelated to the code's nominal pharmaceutical scope. The mismatch suggests either a data classification error or an outlier posting that does not reflect typical buying patterns under this code. State and local procurement activity under this code does not appear to support meaningful business development at this time.

No additional recent opportunities are present in the source to characterize issuing-body mix, geographic spread, or representative solicitation patterns. The Seminole County notice, while tagged to this code, procurement of naloxone and deactivation equipment rather than the pharmaceutical compound the code nominally describes. Without corroborating opportunities, geographic concentration and buying-body diversity cannot be reliably assessed.